Sibylle Loibl

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 12 papers. Top paper: “The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group”.

The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

npj Breast Cancer(2021)10.1038/s41523-021-00346-1

N/A

4.9DataRank · unranked

281 citations

Harry R. Haynes, Elizabeth F. Blackley, Susan Fineberg, Jeffrey Shear, Sophia Turner +73 more

Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group

npj Breast Cancer(2020)10.1038/s41523-020-0154-2

N/A

3.5DataRank · unranked

168 citations

Elisabeth Specht Stovgaard, Eva Balslev, Jeppe Thagaard, Weijie Chen, Sarah Dudgeon +95 more

Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT

Journal of Clinical Oncology(2022)10.1200/jco.22.01065

N/A

2.2DataRank · unranked

59 citations

Gini F. Fleming, István Láng, Eva Ciruelos, Hervé Bonnefoi, Meritxell Bellet +22 more

The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial

Cancer Discovery(2018)10.1158/2159-8290.cd-18-0264

N/A

0.977DataRank · unranked

675 citations

Rosalind J. Cutts, Yuan Liu, Sarah Hrebien, Xin Huang, Kerry Fenwick +8 more

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer

npj Breast Cancer(2020)10.1038/s41523-020-0156-0

N/A

0.801DataRank · unranked

208 citations

Elvire Roblin, Rim S. Kim, Stefan Michiels, Brandon D. Gallas, Weijie Chen +95 more

Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study

British Journal of Sports Medicine(2022)10.1136/bjsports-2021-105132

N/A

0.688DataRank · unranked

97 citations

Sarah J. Lewis, Richard M Martin, Dallas R. English, Terry Boyle, Graham G. Giles +95 more

TROPION-Breast04: a randomized phase III study of neoadjuvant datopotamab deruxtecan (Dato-DXd) plus durvalumab followed by adjuvant durvalumab versus standard of care in patients with treatment-naïve early-stage triple negative or HR-low/HER2− breast cancer

Therapeutic Advances in Medical Oncology(2025)10.1177/17588359251316176

N/A

0.483DataRank · unranked

24 citations

Sara M. Tolaney, Rebecca Dent, Peter Schmid, Jamil Asselah, Qiang Liu +11 more

Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel

Journal of Medical Genetics(2023)10.1136/jmg-2023-109185

N/A

0.269DataRank · unranked

5 citations

Shai Carmi, Saharon Rosset, Rinat Yerushalmi, Aviad Zick, Tamar Yablonski‐Peretz +95 more

Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study

Kölner Universitäts PublikationsServer (Universität zu Köln)(2024)10.17615/q2rq-dt33

N/A

0DataRank · unranked

0 citations

Hoda Anton‐Culver, Marike Gabrielson, Håkan Olsson, Jennifer Stone, Manuela Gago-Domínguez +95 more

Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.40931

N/A

0DataRank · unranked

2 citations

Yue Ren, Yi Zhang, Natalia Siuliukina, Catherine A. Schnabel, Roswitha Kammler +27 more

Caveolin Gene Expression Predicts Clinical Outcomes for Early-Stage HER2-Negative Breast Cancer Treated with Paclitaxel-Based Chemotherapy in the GeparSepto Trial

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0362

N/A

0DataRank · unranked

7 citations

Andreas Schneeweiß, Christian Jackisch, Changxian Shen, Karsten E. Weber, Peter A. Fasching +17 more

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Annals of Oncology(2022)10.1016/j.annonc.2022.09.159

N/A

0DataRank · unranked

450 citations

Judy E. Garber, Richard D. Gelber, Greg Yothers, Manuel Taboada, L. Ross +93 more